Researcher.Life Logo

Journal of Comparative Effectiveness Research : Impact Factor & More

eISSN: 2042-6313pISSN: 2042-6305
JournalOpen Access

Aims and Scope of Journal of Comparative Effectiveness Research

The Journal of Comparative Effectiveness Research is a peer-reviewed medical journal that was established in 2012 and is published by Future Medicine. The editors-in-chief are Sheldon Greenfield (University of California, Irvine) and Eugene Rich (Mathematica Policy Research). The journal covers all aspects of comparative effectiveness research, including patient-centered outcomes research, pharmacoeconomics and health economics, relating to diagnostics, therapeutics, surgical procedures, or other healthcare services or options. Less

Key Metrics

CiteScore
2.8
H-Index
30
Impact Factor
< 5
SJR
Q2Health Policy
SNIP
0.71
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Comparative Effectiveness Research

Journal of Comparative Effectiveness Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BECARIS PUBLISHING
Language English
Frequency Semi-monthly
Article Processing ChargesUSD 3500
Publication Time14
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
Publication Time 14
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Journal of Comparative Effectiveness Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Comparative Effectiveness Research

Are you implementation ready? An alternative patient and healthcare system-centered model for pharma
  • 12 Aug 2026
  • Journal of Comparative Effectiveness Research
Identification of treatment effect modifiers and prognostic factors in newly diagnosed and relapsed or refractory multiple myeloma.
  • 12 Aug 2026
  • Journal of comparative effectiveness research
Iron deficiency treatment pathway in Italy: patients' perceptions of diagnosis and treatment.
  • 28 Nov 2025
  • Journal of comparative effectiveness research
Comparison treatments for basal ganglia hemorrhage: minimally invasive puncture and drainage versus craniotomy versus conservative treatment.
  • 27 Nov 2025
  • Journal of comparative effectiveness research
Adherence, treatment utilization, clinical and economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US.
  • 24 Nov 2025
  • Journal of comparative effectiveness research
Matching-adjusted indirect comparison of kidney function in patients with immunoglobulin A nephropathy treated with nefecon or sparsentan.
  • 20 Nov 2025
  • Journal of comparative effectiveness research
Are you implementation ready? An alternative patient and healthcare system-centered model for pharma
  • 12 Aug 2026
  • Journal of Comparative Effectiveness Research
Identification of treatment effect modifiers and prognostic factors in newly diagnosed and relapsed or refractory multiple myeloma.
  • 12 Aug 2026
  • Journal of comparative effectiveness research
Iron deficiency treatment pathway in Italy: patients' perceptions of diagnosis and treatment.
  • 28 Nov 2025
  • Journal of comparative effectiveness research
Comparison treatments for basal ganglia hemorrhage: minimally invasive puncture and drainage versus craniotomy versus conservative treatment.
  • 27 Nov 2025
  • Journal of comparative effectiveness research
Adherence, treatment utilization, clinical and economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US.
  • 24 Nov 2025
  • Journal of comparative effectiveness research
Matching-adjusted indirect comparison of kidney function in patients with immunoglobulin A nephropathy treated with nefecon or sparsentan.
  • 20 Nov 2025
  • Journal of comparative effectiveness research

FAQs on Journal of Comparative Effectiveness Research